Nigeria vs Western Pacific (WHO region): Hepatitis B surface antigen (HBsAg) prevalence (%)
Nigeria
2.7%
in 2024
Western Pacific (WHO region)
0.4%
in 2024
Nigeria rank
8th
Western Pacific (WHO region) rank
6th
Hepatitis B surface antigen (HBsAg) prevalence (%) over time
- Nigeria
- Western Pacific (WHO region)
How they compare
Nigeria currently reports 2.7% against 0.4% in Western Pacific (WHO region), a difference of 2.3%.
That makes Nigeria's figure about 6.8 times Western Pacific (WHO region)'s.
Across all 10 years both countries report, Nigeria has been ahead every year.
Nigeria ranks 8th and Western Pacific (WHO region) ranks 6th of 194 countries.
Nigeria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Nigeria | Western Pacific (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3.7% | 0.4% | 3.3% | Nigeria |
| 2020s | 3.1% | 0.4% | 2.7% | Nigeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Nigeria or Western Pacific (WHO region)?
- Nigeria, at 2.7% against 0.4% in Western Pacific (WHO region) as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Nigeria and Western Pacific (WHO region)?
- 2.3%, with Nigeria ahead.
- How many years of comparable data are there for Nigeria and Western Pacific (WHO region)?
- 10 years are reported by both, from 2015 to 2024.
- How do Nigeria and Western Pacific (WHO region) rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Nigeria ranks 8th and Western Pacific (WHO region) ranks 6th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.